New collaboration between UW Center for Health and the Global Environment (CHanGE) and EarthLab will accelerate climate research, action and resilience.
More than 10 PhD and MPH students who entered Department of Global Health graduate programs in 2020 were awarded a variety of Research Assistantships and Fellowships. Meet the current UW Department of Global Health batch of RAs and Fellows, learn about their backgrounds and get their first-hand perspectives of life as global health graduate student in 2020-21.
UW Global Health students: DGH faculty and staff want to collaborate with YOU! Gain first-hand experience on global health projects!
Below are current and upcoming projects from DGH researchers and staff who are looking for students to get involved! DGH will hold networking sessions between January 25 and February 5 where students can discuss project opportunities with relevant faculty/staff.
Gita Ramjee Prize Awarded by the International AIDS Society and The Aurum Institute at the HIV Research for Prevention Conference.
Dear DGH community,
Monday, January 18, is Martin Luther King Jr. Day, on which we celebrate Dr. King’s legacy as a civil rights leader. His brilliant leadership, advocacy, and nonviolent civil disobedience were instrumental in fighting segregation and promoting the right to vote. His work and commitment to antiracism continue to inspire.
For nearly three decades, Grace John-Stewart, a professor of global health and epidemiology at the University of Washington School of Public Health, has devoted her career to improving HIV prevention and treatment.
Dear DGH community,
We are reaching out in support and solidarity as we reel from recent events. Today, supporters of President Trump violently entered the US Capitol and disrupted the counting of certified electoral votes, encouraged by the President’s false claims of election fraud. The disruption of our democratic process in Washington, DC and the violence we are witnessing are deeply disturbing. We recognize that these scenes may be distressing, especially to members of our community who have lived through coups and civil unrest.
Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.
MEDIA CONTACT: Susan Gregg - 206.616.6730, sghanson@uw.edu
Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.
Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.
UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.
The U.S. Food and Drug Administration (FDA) has granted emergency use for two new coronavirus vaccines, one developed by the drug company Pfizer and the biotech company BioNTech and the other by the biotech company ModernaTX. Both are mRNA vaccines and have similar structure.
Both vaccines contain modified mRNA that provides the instructions for the synthesis of the SARS-CoV-2 spike glycoprotein antigen. Its mRNA is enveloped in lipid nanoparticles (LNPs) to prevent degradation and enhance uptake into cells.